The deficiency of the tumor suppressor gene PTEN in nearly half of GBM cases is a critical cause contributing to EGFR or VEGFR inhibitor-resistance and correlating with the reduced survival of patients, as this is associated with increased activity of the PI3K/Akt/mTOR pathway [23, 26]. The gene discussed is AKT1; the disease is glioblastoma.